Abstracts
Showing 852 abstracts.
Citation
Florence Momplaisir, Mustafa Hussein, Kathleen Brady, Allison Agwu, David Bennett. Effects of Depressive Symptoms on HIV Suppression at Delivery and Postpartum in P1025. Presented at: CROI 2018.Conference
CROI 2018
Study
P1025
Citation
Lois C. Howland, M.S., M.P.H., D.Ph., Steven Gortmaker, Ph.D., Catherine Spino, Sc.D. Effects of negative life events on CD4% impairment in a group of children with HIV-1 infection.Citation
MG Fowler, M Qin, S Fiscus, JS Currier, B Makanani, FE Martinson, T Chipato, R Browning, D Shapiro, LM Mofenson. Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission. Presented at: CROI 2015; 2015 Feb 24.Conference
CROI 2015
Study
1077BF, 1077FF
Citation
Efficacy and safety of 6 months versus 6 weeks extended nevirapine (NVP) for prevention of postnatal HIV-1 transmission (PMTCT): 18 month follow-up of the HPTN 046 randomized double blind placebo controlled trial. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.Conference
20th Conference on Retroviruses and Opportunistic Infections
Citation
Juan Carlos Salazar, M.D., M.P.H., Pedro E. Cahn, M.D., Carlo Giaquinto, M.D., Ram Yogev, M.D., Jaromir Mikl, Ante Jelaska, M.D. Efficacy and safety profile of APTIVUS oral solution or capsules co-administered with low dose ritonavir (APTIVUS/r) in treatment experienced children and teenagers after two years of treatment (Phase I/IIa study). Presented at: XVII International AIDS Conference.Conference
XVII International AIDS Conference
Study
P1051
Citation
Efficacy of Extended Daily Infant NVP through Age 6 Months Compared to 6 Weeks for Postnatal PMTCT of HIV through Breastfeeding. Presented at: 18th Conference on Retroviruses & Opportunistic Infections.Conference
18th Conference on Retroviruses & Opportunistic Infections
Citation
E. Richard Stiehm, M.D., John S. Lambert, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James Bethel, Ph.D., Jean Whitehouse, Robert Nugent, Ph.D., John ( Jack ) Moye, Jr., M.D., Mary Glenn Fowler, M.D., M.P.H., Bonnie J. Mathieson, Ph.D., Patricia Reichelderfer, Ph.D., George J. Nemo, Ph.D., William A. Meyer, III, Ph.D., Christine Sapan, Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Jorge Gandia, M.D., Gwendolyn B. Scott, M.D., Mary Jo O'Sullivan, M.D., Andrea Kovacs, M.D., Alice M. Stek, M.D., William T. Shearer, M.D., Ph.D., Hunter H. Hammill, M.D. Efficacy Of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission From HIV-Infected Women With Advanced Disease: results of Pediatric AIDS Clinical Trials Group protocol 185.Citation
B Best, E Capparelli, A Stek, E Acosta, E Smith, N Chakhtoura, J Wang, A Hernandez, M Mirochnick. Elvitegravir/cobicistat pharmacokinetics in pregnancy and postpartum. Presented at: CROI 2017; 2017 Feb 16.Conference
CROI 2017
Study
P1026S
Citation
Susan H. Eshleman, M.D., PH.D., Tamara Flys, M. McConnell, F. Matovu, Jessica D. Church, Danstan Bagenda, P. Bakaki, M. Thigpen, C. Eure, Mary Glenn Fowler, M.D., M.P.H. Emergence and fading of nevirapine resistance after first versus repeated use of single dose nevirapine for prevention of mother-to-child HIV transmission: analysis of women and infants in the Repeat Pregnancy Study in Uganda. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.Conference
15th Conference on Retroviruses & Opportunistic Infections
Citation
Sarah Elizabeth Hudelson, B.S., M. McConnell, Danstan Bagenda, Estelle M. Piwowar-Manning, M.T. (A.S.C.P.), Teresa Parsons, Ph.D., Monica L. Nolan, P. Bakaki, M. Thigpen, Mary Glenn Fowler, M.D., M.P.H., Susan H. Eshleman, M.D., PH.D. Emergence and Persistence of Nevirapine-Resistant HIV in Breast Milk after Single-dose NVP Administration. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections